Jubilant Ingrevia Limited has informed the Exchange regarding Outcome of Board Meeting held on May 13, 2025.
JUBLINGREA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 2.9 pts less than Nifty Smallcap 250 and 2.8 pts less than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Jubilant Ingrevia's board approved audited financial results for Q4 and FY ended March 31, 2025, with the auditor (Walker Chandiok & Co LLP) issuing an unmodified (clean) opinion. Consolidated revenue from operations rose modestly to Rs. 4,17,761 lakhs (from Rs. 4,13,580 lakhs), while net profit jumped to Rs. 25,117 lakhs (from Rs. 18,289 lakhs), a growth of about 37%. Standalone net profit surged to Rs. 26,342 lakhs (from Rs. 16,245 lakhs), roughly 62% higher. The board recommended a final dividend of Rs. 2.50 per share, taking total FY25 dividend to Rs. 5 per share, with July 25, 2025 fixed as the record date. The company also disclosed a fresh investment in O2 Renewable Energy XVIII (now an associate) and issuance of Rs. 10,000 lakhs commercial paper post-quarter.
Strong profit growth driven by margin expansion, especially in the Speciality Chemicals segment, is a positive for shareholders, supported by a higher total dividend of Rs. 5 per share. The clean audit opinion and robust operating cash flow of Rs. 50,809 lakhs reinforce financial health, though revenue growth remains flat.